We are live on ! Find out more

Small Cap Healthcare
Stocks Ranked by
Market Capitalization

Name Market cap Price Price
change %
OMER icon
76
Omeros
OMER
$1.35B
$1.35B $18.61 0.76%
KLRA
77
Kailera Therapeutics
KLRA
$1.35B
$1.35B $10.39 5.8%
NBTX
78
Nanobiotix
NBTX
$1.31B
$1.31B $25.75 7.71%
DMRA
79
Damora Therapeutics
DMRA
$1.27B
$1.27B $20.65 2.08%
ORIC icon
80
Oric Pharmaceuticals
ORIC
$1.27B
$1.27B $12.21 2.48%
USPH icon
81
US Physical Therapy
USPH
$1.25B
$1.25B $83.72 1.36%
AVLN
82
Avalyn Pharma
AVLN
$1.25B
$1.25B $28.13 2.59%
OMDA
83
Omada Health Inc
OMDA
$1.25B
$1.25B $20.37 0.2%
REPL icon
84
Replimune Group
REPL
$1.23B
$1.23B $13.07 2.83%
INNV icon
85
InnovAge Holding
INNV
$1.22B
$1.22B $8.96 1.82%
MNKD icon
86
MannKind Corp
MNKD
$1.22B
$1.22B $3.80 3.8%
LBRX
87
LB Pharmaceuticals
LBRX
$1.19B
$1.19B $36.99 0.78%
CRON
88
Cronos Group
CRON
$1.19B
$1.19B $3.23 0.62%
TRAX
89
First Tracks Biotherapeutics
TRAX
$1.19B
$1.19B $33.28 1.89%
MRVI icon
90
Maravai LifeSciences
MRVI
$1.18B
$1.18B $7.90 5.33%
BCAX
91
Bicara Therapeutics
BCAX
$1.17B
$1.17B $17.63 3.13%
OPK icon
92
Opko Health
OPK
$1.16B
$1.16B $1.56 0.64%
IMTX icon
93
Immatics
IMTX
$1.16B
$1.16B $7.59 10.1%
TNDM icon
94
Tandem Diabetes Care
TNDM
$1.15B
$1.15B $16.50 0%
HROW icon
95
Harrow
HROW
$1.14B
$1.14B $30.48 0.42%
FXH icon
96
First Trust Health Care AlphaDEX Fund
FXH
$1.13B
$1.13B $129.51 0.32%
STAA icon
97
STAAR Surgical
STAA
$1.13B
$1.13B $22.47 0.4%
GDRX icon
98
GoodRx Holdings
GDRX
$1.12B
$1.12B $3.28 0.31%
VOR icon
99
Vor Biopharma
VOR
$1.11B
$1.11B $18.69 3.49%
IRMD icon
100
iRadimed
IRMD
$1.09B
$1.09B $85.40 0.12%

Small Cap Healthcare Stocks at a Glance

Healthcare companies develop drugs, build medical devices, run hospitals and insurers, and supply the systems behind patient care. Demand is largely non-discretionary, but returns hinge on drug-pipeline outcomes, patent lives, and reimbursement policy — a mix of defensive services and high-risk, high-reward research bets.

There are 328 small cap Healthcare stocks — companies in the Healthcare sector with a market cap between $250M and $2B — worth a combined $284B.

The largest by market cap are Trevi Therapeutics (TRVI) at $1.98B, Perrigo (PRGO) at $1.98B and Structure Therapeutics (GPCR) at $1.97B.

Among institutional investors, First Tracks Biotherapeutics (TRAX) drew the most net new fund positions in Q2 2026: 150 funds opened new positions.

Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q2 2026.